Xiaodie Liu , Hongqi Li , Ming Yuan , Jipeng Wan , Jianbin Guo , Xiaoyu Dong , Xueyang Jin , Chunrun Yang , Guoyun Wang
{"title":"The epigenetic landscape of tumor-associated macrophages: orchestrating immune evasion in the tumor microenvironment","authors":"Xiaodie Liu , Hongqi Li , Ming Yuan , Jipeng Wan , Jianbin Guo , Xiaoyu Dong , Xueyang Jin , Chunrun Yang , Guoyun Wang","doi":"10.1016/j.canlet.2025.217972","DOIUrl":null,"url":null,"abstract":"<div><div>Tumor-associated macrophages (TAMs), the predominant immune cell population within the tumor immune microenvironment (TIME), play a vital role in promoting immune evasion and driving tumor progression. Beyond their well-established roles in reprogramming oncogenic signaling and silencing tumor suppressors, emerging evidence highlights that epigenetic modifications also critically shape the immunogenic landscape of tumors by modulating the phenotype and function of infiltrating immune cells. The TIME imposes persistent metabolic and inflammatory stressors—such as hypoxia, nutrient deprivation, and lactate accumulation—that profoundly influence the epigenetic and transcriptional states of TAMs, promoting their phenotypic plasticity and skewing them toward immunosuppressive, pro-tumoral phenotypes. Notably, this dynamic and reversible reprogramming closely parallels the defining features of epigenetic regulation, which is inherently sensitive to environmental stimuli and governs cellular identity. In this review, we comprehensively examine how extracellular cues within the TME rewire the expression and activity of key epigenetic regulators in TAMs, activate downstream signaling pathways, and reshape their molecular functions to reinforce tumor-supportive programs. Deciphering these epigenetic circuits provides a framework for therapeutic strategies aimed at re-educating TAMs toward anti-tumor phenotypes and enhancing the efficacy of immunotherapies.</div></div>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":"632 ","pages":"Article 217972"},"PeriodicalIF":10.1000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer letters","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304383525005415","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Tumor-associated macrophages (TAMs), the predominant immune cell population within the tumor immune microenvironment (TIME), play a vital role in promoting immune evasion and driving tumor progression. Beyond their well-established roles in reprogramming oncogenic signaling and silencing tumor suppressors, emerging evidence highlights that epigenetic modifications also critically shape the immunogenic landscape of tumors by modulating the phenotype and function of infiltrating immune cells. The TIME imposes persistent metabolic and inflammatory stressors—such as hypoxia, nutrient deprivation, and lactate accumulation—that profoundly influence the epigenetic and transcriptional states of TAMs, promoting their phenotypic plasticity and skewing them toward immunosuppressive, pro-tumoral phenotypes. Notably, this dynamic and reversible reprogramming closely parallels the defining features of epigenetic regulation, which is inherently sensitive to environmental stimuli and governs cellular identity. In this review, we comprehensively examine how extracellular cues within the TME rewire the expression and activity of key epigenetic regulators in TAMs, activate downstream signaling pathways, and reshape their molecular functions to reinforce tumor-supportive programs. Deciphering these epigenetic circuits provides a framework for therapeutic strategies aimed at re-educating TAMs toward anti-tumor phenotypes and enhancing the efficacy of immunotherapies.
期刊介绍:
Cancer Letters is a reputable international journal that serves as a platform for significant and original contributions in cancer research. The journal welcomes both full-length articles and Mini Reviews in the wide-ranging field of basic and translational oncology. Furthermore, it frequently presents Special Issues that shed light on current and topical areas in cancer research.
Cancer Letters is highly interested in various fundamental aspects that can cater to a diverse readership. These areas include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal actively focuses on experimental therapeutics, particularly the advancement of targeted therapies for personalized cancer medicine, such as metronomic chemotherapy.
By publishing groundbreaking research and promoting advancements in cancer treatments, Cancer Letters aims to actively contribute to the fight against cancer and the improvement of patient outcomes.